4.9 • 3K Ratings
🗓️ 14 July 2025
⏱️ 60 minutes
🧾️ Download transcript
Dr. Spencer Nadolsky joins Ethan on the American Glutton Podcast to dive into the revolutionary impact of GLP-1 drugs on obesity and cardiometabolic health, exploring their benefits, risks, and societal implications. From debunking myths about weight loss to discussing emerging treatments like myostatin inhibitors, they tackle the science and real-world applications head-on. The conversation also touches on the future of these medications, their potential to prevent weight gain, and the importance of combining them with lifestyle changes like resistance training.
SHOW HIGHLIGHTS
00:00 - Introduction and Catching Up
00:35 - Obesity as a Choice and GLP-1 Drugs
01:58 - Misuse of GLP-1s and Social Media Hype
05:08 - The Science Behind GLP-1 and Incretin Effect
07:37 - How GLP-1 Drugs Work for Weight Loss
10:00 - Benefits vs. Risks of GLP-1 Drugs
11:57 - Common Side Effects and Nausea Discussion
13:15 - Fatigue and Anhedonia as Side Effects
14:54 - Fat Cell Memory and Weight Regain
17:41 - GLP-1s as a Breakthrough for Obesity
19:33 - Comparing Risks of GLP-1s to Other Drugs
20:24 - Big Pharma and Advisory Boards
23:57 - Importance of Protein and Resistance Training
27:34 - Myostatin Inhibitors and Muscle Growth
31:39 - Timeline for New Drug Approvals
33:31 - Drug Costs and Accessibility
37:51 - Comparing GLP-1 Drugs and Zepbound
39:57 - Glucagon and Triple Agonist Drugs
41:58 - Future of GLP-1s in Preventing Weight Gain
43:43 - Microdosing and Anti-Inflammatory Effects
44:33 - GLP-1s and Type 1 Diabetes Considerations
48:50 - Historical Context and Obesity Trends
52:37 - Moralizing Weight and Pharmaceutical Solutions
54:03 - Closing Thoughts and Future Support
Hosted on Acast. See acast.com/privacy for more information.
Click on a timestamp to play from that location
| 0:00.0 | Thinking you've made a mistake with your uni choice? |
| 0:02.0 | Maybe you've changed your mind about those big lecture halls and that theory-heavy course. |
| 0:06.0 | It's not too late to choose a practically focused law degree that gets you career ready. |
| 0:09.0 | Switching through clearing isn't settling for second best. |
| 0:12.0 | It's giving you more opportunities to find your perfect match. |
| 0:15.0 | At the University of Law, you'll benefit from more academic coaching, more hands-on learning, |
| 0:20.0 | and more tailored support |
| 0:20.9 | to achieve your ambitions. Our dedicated clearing team are ready to match you to the right law |
| 0:25.1 | course today. Apply to the University of Law through clearing. Your successful career in law |
| 0:29.2 | starts here. Let QVC help your garden become summer ready. Whether it's an entertaining space |
| 0:36.2 | for friends and family or a tranquil spot for some me time, |
| 0:39.8 | My Garden Escape at QVC has all you need. |
| 0:42.8 | Discover beautiful indoor and outdoor plants, |
| 0:45.4 | tools, stylish furniture, accessories and more, |
| 0:47.9 | all at your fingertips. |
| 0:49.3 | So whether you're a seasoned gardener or just starting out, |
| 0:52.8 | My Garden Escape at QVC can help get your outdoor space ready for summer shop now |
| 0:57.9 | at kvcukk dot com better help online therapy bought this 30 second ad to remind you right now wherever you are |
| 1:08.2 | to unclench your jaw relax your shoulders take a deep breath in |
| 1:15.6 | and out feels better right that's 15 seconds of self-care imagine what you could do with more |
| 1:26.6 | visit betterhelp.com forward slash random pod for 10% |
| 1:31.4 | off your first month of therapy. No pressure. Just help. But for now, just relax. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from American Glutton, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of American Glutton and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.